Vaginal DHEA for Women After Breast Cancer

Vaginal DHEA to Ease Vaginal Dryness in Women With a Contraindication to Estrogen Therapy

There does not appear to be a consensus regarding the treatment of vaginal dryness in women who have a contraindication to the use of estrogen products. DHEA, when used locally, may improve the symptoms of vaginal dryness due to its chemical properties.

Inclusion Criteria:

• women post menopausal aged 35-55, suffering from vaginal dryness, secondary to chemotherapy for breast cancer, within 5 years of diagnosis. Follicle Stimulating Hormone and Estradiol levels in the post menopausal range are needed.

Exclusion Criteria:

• women using products to alleviate vaginal dryness.
• women taking medication for urinary incontinence
• women not sexually active, for other reasons.